S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
NASDAQ:NXGN

NextGen Healthcare Competitors

$18.70
+0.33 (+1.80 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$18.24
Now: $18.70
$19.02
50-Day Range
$18.23
MA: $20.27
$23.35
52-Week Range
$5.10
Now: $18.70
$23.80
Volume479,442 shs
Average Volume409,720 shs
Market Capitalization$1.25 billion
P/E Ratio116.88
Dividend YieldN/A
Beta1.23

Competitors

NextGen Healthcare (NASDAQ:NXGN) Vs. SGMS, PSN, VRNT, MDRX, TLS, and NTCT

Should you be buying NXGN stock or one of its competitors? Companies in the industry of "computer integrated systems design" are considered alternatives and competitors to NextGen Healthcare, including Scientific Games (SGMS), Parsons (PSN), Verint Systems (VRNT), Allscripts Healthcare Solutions (MDRX), Telos (TLS), and NetScout Systems (NTCT).

Scientific Games (NASDAQ:SGMS) and NextGen Healthcare (NASDAQ:NXGN) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Scientific Games and NextGen Healthcare, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Scientific Games02402.67
NextGen Healthcare16502.33

Scientific Games currently has a consensus target price of $39.2857, suggesting a potential downside of 16.11%. NextGen Healthcare has a consensus target price of $16.50, suggesting a potential downside of 11.76%. Given NextGen Healthcare's higher possible upside, analysts clearly believe NextGen Healthcare is more favorable than Scientific Games.

Profitability

This table compares Scientific Games and NextGen Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Scientific Games-18.48%N/A-3.74%
NextGen Healthcare1.80%11.28%6.57%

Earnings & Valuation

This table compares Scientific Games and NextGen Healthcare's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scientific Games$3.40 billion1.31$-130,000,000.00$0.23203.61
NextGen Healthcare$540.24 million2.32$7.50 million$0.5931.69

NextGen Healthcare has lower revenue, but higher earnings than Scientific Games. NextGen Healthcare is trading at a lower price-to-earnings ratio than Scientific Games, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

89.5% of Scientific Games shares are held by institutional investors. Comparatively, 71.3% of NextGen Healthcare shares are held by institutional investors. 40.6% of Scientific Games shares are held by insiders. Comparatively, 18.5% of NextGen Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility & Risk

Scientific Games has a beta of 2.11, meaning that its share price is 111% more volatile than the S&P 500. Comparatively, NextGen Healthcare has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Summary

NextGen Healthcare beats Scientific Games on 9 of the 14 factors compared between the two stocks.

Parsons (NYSE:PSN) and NextGen Healthcare (NASDAQ:NXGN) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Parsons and NextGen Healthcare, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Parsons12302.33
NextGen Healthcare16502.33

Parsons currently has a consensus target price of $38.50, suggesting a potential upside of 7.72%. NextGen Healthcare has a consensus target price of $16.50, suggesting a potential downside of 11.76%. Given Parsons' higher possible upside, research analysts clearly believe Parsons is more favorable than NextGen Healthcare.

Profitability

This table compares Parsons and NextGen Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Parsons2.27%10.08%4.79%
NextGen Healthcare1.80%11.28%6.57%

Earnings & Valuation

This table compares Parsons and NextGen Healthcare's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Parsons$3.95 billion0.91$120.53 million$1.4624.48
NextGen Healthcare$540.24 million2.32$7.50 million$0.5931.69

Parsons has higher revenue and earnings than NextGen Healthcare. Parsons is trading at a lower price-to-earnings ratio than NextGen Healthcare, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

71.3% of NextGen Healthcare shares are held by institutional investors. 0.2% of Parsons shares are held by insiders. Comparatively, 18.5% of NextGen Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility & Risk

Parsons has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, NextGen Healthcare has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Summary

NextGen Healthcare beats Parsons on 8 of the 13 factors compared between the two stocks.

Verint Systems (NASDAQ:VRNT) and NextGen Healthcare (NASDAQ:NXGN) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Verint Systems and NextGen Healthcare, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Verint Systems00703.00
NextGen Healthcare16502.33

Verint Systems currently has a consensus target price of $65.8571, suggesting a potential upside of 33.61%. NextGen Healthcare has a consensus target price of $16.50, suggesting a potential downside of 11.76%. Given Verint Systems' stronger consensus rating and higher possible upside, research analysts clearly believe Verint Systems is more favorable than NextGen Healthcare.

Profitability

This table compares Verint Systems and NextGen Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Verint Systems1.51%13.19%5.33%
NextGen Healthcare1.80%11.28%6.57%

Earnings & Valuation

This table compares Verint Systems and NextGen Healthcare's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verint Systems$1.30 billion2.49$28.68 million$2.6218.81
NextGen Healthcare$540.24 million2.32$7.50 million$0.5931.69

Verint Systems has higher revenue and earnings than NextGen Healthcare. Verint Systems is trading at a lower price-to-earnings ratio than NextGen Healthcare, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

95.9% of Verint Systems shares are held by institutional investors. Comparatively, 71.3% of NextGen Healthcare shares are held by institutional investors. 1.4% of Verint Systems shares are held by insiders. Comparatively, 18.5% of NextGen Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility & Risk

Verint Systems has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, NextGen Healthcare has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Summary

Verint Systems beats NextGen Healthcare on 10 of the 14 factors compared between the two stocks.

Allscripts Healthcare Solutions (NASDAQ:MDRX) and NextGen Healthcare (NASDAQ:NXGN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Institutional and Insider Ownership

71.3% of NextGen Healthcare shares are held by institutional investors. 1.4% of Allscripts Healthcare Solutions shares are held by insiders. Comparatively, 18.5% of NextGen Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Allscripts Healthcare Solutions and NextGen Healthcare, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Allscripts Healthcare Solutions47502.06
NextGen Healthcare16502.33

Allscripts Healthcare Solutions currently has a consensus target price of $10.8667, suggesting a potential downside of 29.57%. NextGen Healthcare has a consensus target price of $16.50, suggesting a potential downside of 11.76%. Given NextGen Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe NextGen Healthcare is more favorable than Allscripts Healthcare Solutions.

Volatility & Risk

Allscripts Healthcare Solutions has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Comparatively, NextGen Healthcare has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Earnings & Valuation

This table compares Allscripts Healthcare Solutions and NextGen Healthcare's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allscripts Healthcare Solutions$1.77 billion1.38$-182,180,000.00$0.4732.83
NextGen Healthcare$540.24 million2.32$7.50 million$0.5931.69

NextGen Healthcare has lower revenue, but higher earnings than Allscripts Healthcare Solutions. NextGen Healthcare is trading at a lower price-to-earnings ratio than Allscripts Healthcare Solutions, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Allscripts Healthcare Solutions and NextGen Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Allscripts Healthcare Solutions-2.77%5.80%2.26%
NextGen Healthcare1.80%11.28%6.57%

Summary

NextGen Healthcare beats Allscripts Healthcare Solutions on 12 of the 13 factors compared between the two stocks.

NextGen Healthcare (NASDAQ:NXGN) and Telos (NASDAQ:TLS) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Insider & Institutional Ownership

71.3% of NextGen Healthcare shares are owned by institutional investors. 18.5% of NextGen Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations for NextGen Healthcare and Telos, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NextGen Healthcare16502.33
Telos00703.00

NextGen Healthcare currently has a consensus price target of $16.50, suggesting a potential downside of 11.76%. Telos has a consensus price target of $35.8571, suggesting a potential upside of 7.61%. Given Telos' stronger consensus rating and higher possible upside, analysts plainly believe Telos is more favorable than NextGen Healthcare.

Valuation and Earnings

This table compares NextGen Healthcare and Telos' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NextGen Healthcare$540.24 million2.32$7.50 million$0.5931.69
TelosN/AN/AN/AN/AN/A

NextGen Healthcare has higher revenue and earnings than Telos.

Profitability

This table compares NextGen Healthcare and Telos' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NextGen Healthcare1.80%11.28%6.57%
TelosN/AN/AN/A

Summary

NextGen Healthcare beats Telos on 6 of the 9 factors compared between the two stocks.

NextGen Healthcare (NASDAQ:NXGN) and NetScout Systems (NASDAQ:NTCT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Insider & Institutional Ownership

71.3% of NextGen Healthcare shares are owned by institutional investors. Comparatively, 94.7% of NetScout Systems shares are owned by institutional investors. 18.5% of NextGen Healthcare shares are owned by company insiders. Comparatively, 4.4% of NetScout Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations for NextGen Healthcare and NetScout Systems, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NextGen Healthcare16502.33
NetScout Systems03002.00

NextGen Healthcare currently has a consensus price target of $16.50, suggesting a potential downside of 11.76%. NetScout Systems has a consensus price target of $24.6667, suggesting a potential downside of 12.59%. Given NextGen Healthcare's stronger consensus rating and higher possible upside, equities research analysts plainly believe NextGen Healthcare is more favorable than NetScout Systems.

Risk & Volatility

NextGen Healthcare has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, NetScout Systems has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.

Valuation and Earnings

This table compares NextGen Healthcare and NetScout Systems' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NextGen Healthcare$540.24 million2.32$7.50 million$0.5931.69
NetScout Systems$891.82 million2.32$-2,750,000.00$1.0028.22

NextGen Healthcare has higher earnings, but lower revenue than NetScout Systems. NetScout Systems is trading at a lower price-to-earnings ratio than NextGen Healthcare, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares NextGen Healthcare and NetScout Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NextGen Healthcare1.80%11.28%6.57%
NetScout Systems2.61%4.77%2.99%

Summary

NextGen Healthcare beats NetScout Systems on 9 of the 14 factors compared between the two stocks.


NextGen Healthcare Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Scientific Games logo
SGMS
Scientific Games
1.4$46.83+5.9%$4.46 billion$3.40 billion-8.47Upcoming Earnings
Unusual Options Activity
PSN
Parsons
1.0$35.74+1.5%$3.60 billion$3.95 billion39.71Earnings Announcement
Analyst Downgrade
Verint Systems logo
VRNT
Verint Systems
1.7$49.29+0.9%$3.24 billion$1.30 billion205.38
Allscripts Healthcare Solutions logo
MDRX
Allscripts Healthcare Solutions
0.7$15.43+2.0%$2.44 billion$1.77 billion-51.43Earnings Announcement
Analyst Report
High Trading Volume
News Coverage
TLS
Telos
1.6$33.32+3.9%$2.08 billionN/A0.00Upcoming Earnings
NetScout Systems logo
NTCT
NetScout Systems
1.2$28.22+1.1%$2.07 billion$891.82 million94.07
Sykes Enterprises logo
SYKE
Sykes Enterprises
1.5$40.86+0.1%$1.62 billion$1.61 billion30.95Earnings Announcement
Analyst Downgrade
Insider Selling
Analyst Revision
Unisys logo
UIS
Unisys
1.0$24.55+2.0%$1.55 billion$2.95 billion1.68Earnings Announcement
Simulations Plus logo
SLP
Simulations Plus
1.8$71.72+0.2%$1.43 billion$41.59 million140.63Insider Selling
Agilysys logo
AGYS
Agilysys
1.4$59.59+1.1%$1.41 billion$160.76 million-53.20
Ribbon Communications logo
RBBN
Ribbon Communications
1.4$8.64+5.4%$1.26 billion$563.11 million-5.24Analyst Upgrade
High Trading Volume
Gap Up
OSPN
OneSpan
1.6$23.36+3.1%$949.21 million$254.57 million584.15Earnings Announcement
Analyst Revision
Ebix logo
EBIX
Ebix
1.7$24.38+2.6%$754.88 million$580.61 million7.92Upcoming Earnings
Dividend Announcement
Unusual Options Activity
News Coverage
Gap Down
Digimarc logo
DMRC
Digimarc
0.9$36.59+5.0%$560.41 million$22.99 million-13.21Earnings Announcement
TUFN
Tufin Software Technologies
1.0$12.30+0.2%$398.96 million$103.27 million-11.39
Asure Software logo
ASUR
Asure Software
1.8$7.79+0.1%$144.68 million$73.15 million3.90
Streamline Health Solutions logo
STRM
Streamline Health Solutions
0.9$2.14+12.6%$67.76 million$20.74 million-53.50High Trading Volume
Gap Up
BRQS
Borqs Technologies
0.4$1.59+3.8%$61.82 million$98.96 million0.00
AVCT
American Virtual Cloud Technologies
1.3$6.72+1.9%$53.31 millionN/A0.00
KBNT
Kubient
1.0$6.91+14.9%$53.19 millionN/A0.00Upcoming Earnings
Gap Up
CSPI
CSP
0.5$8.39+3.6%$35.88 million$61.79 million-23.30
CREX
Creative Realities
0.7$2.74+2.2%$29.99 million$31.60 million-1.71News Coverage
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.